# Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

> **NCT00321737** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 445 (actual)

## Conditions studied

- Esophagitis, Reflux
- Esophagitis, Peptic

## Interventions

- **DRUG:** Dexlansoprazole MR
- **DRUG:** Dexlansoprazole MR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00321737
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 445 (ACTUAL)
- **Last updated:** 2012-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00321737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00321737, "Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00321737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*